Please log in to view this page
Username
Password
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
